Literature DB >> 25016325

Counselee participation in follow-up breast cancer genetic counselling visits and associations with achievement of the preferred role, cognitive outcomes, risk perception alignment and perceived personal control.

Akke Albada1, Margreet G E M Ausems2, Sandra van Dulmen3.   

Abstract

The purpose of the study was to assess the counselee participation in the follow-up visits, compared to the first visits, for breast cancer genetic counselling and to explore associations with counselees' achievement of their preferred role in decision making, information recall, knowledge, risk perception alignment and perceived personal control. First and follow-up visits for breast cancer genetic counselling of 96 counselees of a Dutch genetics center were videotaped (2008-2010). Counselees completed questionnaires before counselling (T1), after the follow-up visit (T2) and one year after the follow-up visit (T3). Consultations were rated with the Roter Interaction Analysis System (RIAS). Counselee participation was measured as the percentage of counselee utterances, the percentage of counselee questions and the interactivity (number of turns per minute). Follow-up visits had higher levels of counselee participation than first visits as assessed by the percentage of counselee talk, the interactivity and counselee questions. More counselee talk in the follow-up visit was related to higher achievement of the preferred role (T2) and higher perceived personal control (T3). Higher interactivity in the follow-up visit was related to lower achievement of the preferred role in decision making and lower information recall (T2). There were no significant associations with the percentage of questions asked and none of the participation measures was related to knowledge, risk perception alignment and perceived personal control (T2). In line with the interviewing admonishment 'talk less and listen more', the only assessment of counselee participation associated to better outcomes is the percentage of counselee talk. High interactivity might be associated with lower recall in breast cancer genetic counselees who are generally highly educated. However, this study was limited by a small sample size and a heterogeneous group of counselees. Research is needed on the interactions causing interactivity and its relationships with involvement in decision making and recall.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Communication; Genetic counselling; Interaction analysis

Mesh:

Year:  2014        PMID: 25016325     DOI: 10.1016/j.socscimed.2014.07.012

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  4 in total

1.  An observational study of social and emotional support in smoking cessation Twitter accounts: content analysis of tweets.

Authors:  Mary Rocheleau; Rajani Shankar Sadasivam; Kate Baquis; Hannah Stahl; Rebecca L Kinney; Sherry L Pagoto; Thomas K Houston
Journal:  J Med Internet Res       Date:  2015-01-14       Impact factor: 5.428

2.  Evaluation of psychosocial aspects in participants of cancer genetic counseling.

Authors:  Leivy Patricia González-Ramírez; Reyna Martínez-Arriaga; Erendira Camacho-Cárdenas; Azucena Del Toro-Valero; Antonio Oceguera-Villanueva; Livia Zagamé; Aída Araceli Silva-García; Adrián Daneri-Navarro
Journal:  Hered Cancer Clin Pract       Date:  2017-09-20       Impact factor: 2.857

Review 3.  The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review.

Authors:  Kyra Bokkers; Michiel Vlaming; Ellen G Engelhardt; Ronald P Zweemer; Inge M van Oort; Lambertus A L M Kiemeney; Eveline M A Bleiker; Margreet G E M Ausems
Journal:  Cancers (Basel)       Date:  2022-02-19       Impact factor: 6.639

4.  Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.

Authors:  Akke Albada; Sandra van Dulmen; Henrietta Dijkstra; Ivette Wieffer; Arjen Witkamp; Margreet G E M Ausems
Journal:  J Genet Couns       Date:  2015-09-01       Impact factor: 2.537

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.